Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Mar-Apr;23(2-3):177-82.
doi: 10.1385/ENDO:23:2-3:177.

The role of TNF-alpha in insulin resistance

Affiliations
Review

The role of TNF-alpha in insulin resistance

Stephen E Borst. Endocrine. 2004 Mar-Apr.

Abstract

Insulin resistance is an important component of the metabolic syndrome associated with obesity. Early-stage insulin-resistance and related mild glucose intolerance may be compensated by increased insulin secretion. When combined with impaired insulin secretion, insulin resistance plays an important role in type 2 diabetes (1). Insulin-resistance is also associated with a variety of pathological conditions, including trauma, infection, and cancer. Obesity and type 2 diabetes are the most common metabolic diseases in Western societies, together affecting as much as half of the adult population (2). The prevalence of these conditions is not only high, but continues to increase. We have only recently come to appreciate the role of fat, especially visceral fat, as an endocrine organ. Visceral fat is the source of a number of substances which might play a role in the development of insulin resistance. Among the latter are tumor necrosis factor-alpha (TNF-alpha), adiponectin, IL-6, resistin and free fatty acids. This review will discuss the regulation of insulin responses by TNF-alpha and evidence supporting the hypothesis that over expression of TNF-alpha plays a role in the pathophysiology of insulin resistance.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Med Res Rev. 1997 Sep;17(5):477-98 - PubMed
    1. Am J Physiol. 1999 May;276(5):E849-55 - PubMed
    1. Lancet. 1997 Feb 22;349(9051):521-4 - PubMed
    1. J Clin Invest. 1996 Feb 15;97(4):1111-6 - PubMed
    1. Am J Physiol. 1995 Nov;269(5 Pt 2):R1204-12 - PubMed

MeSH terms

LinkOut - more resources

  NODES
twitter 2